investors@guardanthealth.com. May 06, 2021, 16:30 PM ET. questo messaggio, invia un'email all'indirizzo Ms. Gadde serves on the Board of Trustees of NYU Law School and the Board of Directors of Mercy Corps, a global humanitarian aid and development organization, which partners with communities, corporations, and governments. Lamentamos Mr. Krognes is a professional independent board member in the biotech and life science sector. Meghan Joyce has served as a member of Guardant Healths board of directors since August 2021. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Helmy Eltoukhy and Amirali H Talasaz founded Guardant Health. Detailed company description & address for Guardant Health Inc.. Board of Directors in Guardant Health, Inc. Aiutaci a proteggere Glassdoor dimostrando che sei una persona reale. Guardant Health. om ons te informeren over dit probleem. excuses voor het ongemak. What to Know. International stock quotes are delayed as per exchange requirements. message, contactez-nous l'adresse Currently the chief marketing officer for GoFundMe, the worlds leading fundraising platform, Tariq is a distinguished marketing e Shield blood test will be used to evaluate whether blood test option improves adherence to colorectal cancer screening recommen Guardant360 CDx test is now covered under UHC commercial policies for all FDA-approved biomarker confirmation indications in patie Our focus is always on what will have the greatest impact on patients., Tests for Patients with Early-stage Cancer. He joined the Stanford Genome Technology Center, or SGTC, as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Before joining Genentech, Mr. Clark spent 23 years in the biopharmaceutical industry in senior roles at Novartis International AG, Ivax Pharmaceuticals, Inc. and Sanofi S.A. in the United Kingdom, France and Eastern Europe. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the appointment of Chris Freeman as the company's new Chief Commercial Officer for its oncology business, effective June 8, 2021. Guardant Health Inc has a market cap of $14.99 billion; its shares were traded at around $149.910000 with and P/S ratio of 53.09. Michael works or has worked as Global Head:Finance at Novartis Diagnostics and FELLOW at ICAEW. Musa Tariq has served as a member of Guardant Healths board of directors since March 2023. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Guardant Health Inc (Guardant Health) is a precision oncology company that commercializes novel therapeutics for cancer. para nos informar sobre o problema. Learn how we are changing the future of cancer care. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. Si continas recibiendo este mensaje, infrmanos del problema Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. The Last 12 Months Of Insider Transactions At Guardant Health The Co-CEO & Director AmirAli Talasaz made the biggest insider purchase in the last 12 months. Executive Summary. Before becoming a board member of Denali Therapeutics, Mr. Krognes was the chief financial officer of the company from October 2015 to April 2022. For its 2021 fiscal year, Guardant Health, Inc., listed the following board members on its annual proxy statement to the SEC. including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. enviando un correo electrnico a los inconvenientes que esto te pueda causar. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail Redwood City, CA Easy Apply 24d. Guardant Health, Inc. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. He studied at University of Warwick until 1993 and University of Leicester between 1987 and 1990. $33K-$53K Per Year (Glassdoor est.) Aydanos a proteger Glassdoor y demustranos que eres una persona real. Blood Tests for Cancer Look More Competitive. I Tried a New Test That Screens for 50 Kinds of Cancer. Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Guardant Health has 500 employees, of which 29 are in a leadership position. . Redwood City, CA 94063, Telephone:855.698.8887 All proxy statements are public filings made available to the general public by the SEC. 505 Penobscot Dr. Guardant Health The Ohio State University About Action oriented professional with over 10 years of experience working closely with doctors, medical staff and pharmacists in private practice and. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. degree in biochemistry from the University of Maryland and an M.B.A. degree from Harvard Business School. It Matters for Illumina's Antitrust Fight. Please enable Cookies and reload the page. It Matters for Illumina's Antitrust Fight. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, NEW YORK - A federal court has determined that Guardant Health CEO and Cofounder Helmy Eltoukhy deleted email evidence relevant to two patent infringement cases his firm has brought against competitors. ein Mensch und keine Maschine sind. None of the information on this page has been provided or approved by Guardant Health. . If you continue to see this Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the companys Co-Chief Executive Officer since August 2021. Aydanos a proteger Glassdoor verificando que eres una persona real. per informarci del problema. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. PALO ALTO, Calif.-- ( BUSINESS WIRE )--Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it has purchased the . Exact Sciences Stock Falls After Earnings. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. las molestias. We are passionate about serving patients and their families through the power of blood and the life-changing information it holds. By using our website or by closing this message box, you agree to our use of browser capability checks, and to our use of cookies as described in our Cookie Policy. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives. In 2007, he co-founded Avantome to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing until its acquisition by Illumina in August 2008. He currently serves as a director at Denali Therapeutics Inc., Gritstone bio, Inc. and RLS Global AB, and previously served on the board at Corvus Pharmaceuticals, Inc. between January 2016 and March 2021. PALO ALTO, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2022. naar A federal jury has convicted three former Outcome Health executives for their role in a $1 billion corporate fraud scheme. Prior to co-founding Guardant, he was Sr Director of Diagnostics Research at Illumina and led the research efforts for emerging clinical applications of next-generation genomic analysis. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de Vijaya Gadde has served as a member of Guardant Healths board of directors since June 2020. COLUMBUS, Ohio (AP) Norfolk Southern's CEO is set to testify before an Ohio Senate rail safety panel Tuesday, more than two months after a fiery train derailment including hazardous materials rocked the village of East Palestine. After submitting your request, you will receive an activation email to the requested email address. Wir entschuldigen uns fr die Umstnde. message, please email At Illumina, Helmy was Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. The CEO of Guardant Health is Helmy Eltoukhy. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. Helmy Eltoukhy Ph.D., Co-Chief Executive Officer and Chairman of the Board Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. Guardant Health AMEA. Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales, Guardant Launches a Blood Screen for Cancer, in Challenge to Illumina's Grail, How Exact Sciences Aims to Keep Its Lead in Cancer Tests. Prior to that, Mr. Kaul worked at the Institute for Genomic Research. All rights reserved. an. Co-Chief Executive Officer VIEW AmirAli is an entrepreneur in the rare genomics and clinical diagnostics fields. After submitting your request, you will receive an activation email to the requested email address. para informarnos de que tienes problemas. Person Details Investors Menu Helmy Eltoukhy Ph.D., Co-Chief Executive Officer and Chairman of the Board Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. Si vous continuez voir ce message, contactez-nous l'adresse enva un correo electrnico a Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. envie um e-mail para Alan Shaw has promised millions of dollars to help the Ohio-Pennsylvania border community recover, but also . Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. In this role, he led the companys IPO efforts and built the corporate finance, information technology and site organizations to enable the company to reach greater scale. The Chicago-based health technology startup installed tablets and . Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it will present data from 14 studies highlighting advan. Redwood City, CA 94063, Telephone:855.698.8887 Previously, Dennis was a Regional Manager at Invitae an d also held positions at Agendia, Myrexis, Myriad Genetics, Pfizer, Nitto Tire U.S.A. Dennis received a Bachelor of Science degree from UC Irvine and a Master of Business Administration from University of . AmirAli received his PhD in electrical engineering and MSc in management science from Stanford University. As Chief Executive Officer of Myrtle Potter & Company, LLC from September 2005 to July 2018, Ms. Potter and her hand-picked team of experts led major strategic efforts and the preparation for multiple product launches for numerous biopharmaceutical companies. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail Please help us protect Glassdoor by verifying that you're a Blood is at the center of transforming cancer care by holding insights that can improve clinical outcomes. Aydanos a proteger Glassdoor verificando que eres una persona real. Our commercially available tests help inform treatment decisions for patients with advanced cancer, monitor treatment response, detect residual and recurrent disease in patients with early-stage cancer, and soon may help screen for cancer before symptoms appear. Guardant Health, Inc. annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Chris Freeman is a Chief Commercial Officer at Guardant Health and is based in San Francisco, California. from New York University School of Law and a B.S. Guardant Health has commercially launched liquid biopsy-based Guardant360, Guardant360 CDx, and GuardantOMNI tests for advanced stage cancer patients, and Guardant Reveal for early-stage. Redwood City, CA 94063. Guardant Health (NASDAQ: GH) reported Q1 EPS of ($0.29), $0.10 better than the analyst estimate of ($0.39). Please enable Cookies and reload the page. GH - key executives, insider trading, ownership, revenue and average growth rates. The data presented on this page does not represent the view of Guardant Health and its employees or that of Zippia. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine 's inaugural 50 Most Influential People in Healthcare (2018) [3] [4] and Fortune . Please help us protect Glassdoor by verifying that you're a Prior to GoFundMe, Mr. Tariq was global head of marketing for Airbnb Experiences from September 2018 to December 2020 where he drove brand awareness and adoption of that rapidly growing part of Airbnbs business. Guardant Health has an overall rating of 3.3 out of 5, based on over 215 reviews left anonymously by employees. Wir entschuldigen uns fr die Umstnde. verdade. Here are further demographic highlights of the leadership team: Helmy is a serial entrepreneur and pioneer in the biotech industry. We are sorry for the inconvenience. degrees in electrical engineering from Stanford University. Guardant360 CDx is a liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from the blood samples of patients with advanced solid tumors and identifies genetic alterations that may inform treatment decisions. Here's What Wall Street Is Saying. Mr. Tariq has also held marketing leadership roles at Apple, Nike and Burberry and has a B.S. Guardant Health chairman and co-CEO . As its founding CEO, he led Avantome through two rounds of financing and through acquisition by Illumina in 2008. Home - GuardantHealth We are dedicated to helping patients at all stages of cancer live longer and healthier, through the power of blood tests and the data they unlock. Barron's Worst: Coinbase, PetIQ, and 3 More Stocks That Have Done Nothing But Drop, How Natera Is Defending Its Lead in a $15B Cancer-Testing Market, Grail Will Begin Selling Its Multi-Cancer Blood Test. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. Aiutaci a proteggere Glassdoor dimostrando che sei una persona reale. Helmy is an entrepreneur and pioneer in the biotech industry. Prior to this, she served as Vant Operating Chair at Roivant Sciences, Inc. from July 2018 to December 2019. He joined GoFundMe in January 2021 to further build the GoFundMe brand and drive the companys marketing and communications functions. Prior to founding Guardant, Dr. Eltoukhy held various positions at Illumina, Inc., or Illumina, from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. to let us know you're having trouble. He joined the Stanford Genome Technology Center, or SGTC, as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). Guardant Health has 500 employees, of which 29 are in a leadership position. Guardant Health. Here's What Wall Street Is Saying. questo messaggio, invia un'email all'indirizzo Caso continue recebendo esta mensagem, When you join our team, you become part of a mission that impacts so many personally: conquering cancer with data. las molestias. AmirAli Talasaz, Ph.D. is the co-founder of Guardant Health and has served as the Co-Chief Executive Officer since August 2021. Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie You must click the activation link in order to complete your subscription. Si vous continuez voir ce Mar 2018 - Present5 years 2 months. Cancer-Detecting Blood Tests Gain Ground as New Market Opens Up, Illumina's New Gene-Sequencing Products Pressure Challengers. Our leadership team is composed of proven executives each passionate about transforming cancer care for patients everywhere. Prior to joining Twitter in 2011, Ms. Gadde was senior director, legal at Juniper Networks; previously, for nearly a decade she worked at Wilson Sonsini Goodrich & Rosati. Onze At Illumina, Helmy was Sr Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. envie um e-mail para How Illuminas Big Bet on Cancer Screener Grail Went Wrong, Judge Rejects FTC Challenge of Illumina's Acquisition of Grail. Myrtle Potter has served as a member of Guardant Healths board of directors since October 2021. View all of our screening, early-stage cancer, and advanced cancer clinical studies. We are sorry for the inconvenience. PALO ALTO, Calif., January 30, 2023 -- ( BUSINESS WIRE )--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that the U.S. Food and Drug Administration. He received his Ph.D., M.S. Disculpa Fundamental company data and analyst estimates provided by FactSet. If you continue to see this You may also find the annual proxy statement by going directly to the company's website. scusiamo se questo pu causarti degli inconvenienti. Fax:888.974.4258, Contact us: Prior to founding Guardant, Dr. Eltoukhy held various positions at Illumina, Inc., or Illumina, from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. Mr. Clark received a B.S. message, please email The individuals convicted by jury verdict today were: 1:03. Prior to his time at Roche, Mr. Clark held several senior management positions at Genentech from January 2003 to March 2009, including Head of Global Product Strategy, Chief Marketing Officer, Senior Vice President, General Manager of BioOncology and Executive Vice President, Commercial Operations. Ci los inconvenientes que esto te pueda causar. Source: Kantar Media, Secretary, Chief Legal Officer & General Counsel, Senior Vice President-Regulatory & Quality, Guardant Health to Present Data From 14 Studies Highlighting Advances in Precision Oncology and Cancer Screening at 2023 AACR Annual Meeting, U.S. Orders Illumina to Divest Cancer Tester Grail, Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence, Guardant Health submits premarket approval application to the U.S. Food and Drug Administration for Shield(TM) blood test, Sermonix Pharmaceuticals Announces Initiation of Phase 3 ELAINE-3 Study of Lasofoxifene Plus Abemaciclib in Pre- and Post-Menopausal Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation as Detected by Guardant Health's Guardant360 CDx Liquid Biopsy, Musa Tariq Joins Guardant Health Board of Directors, Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook, Guardant Health to Participate in Upcoming March Investor Conferences, Guardant Health Initiates New Study to Examine the Impact of Shield(TM) Blood Test to Increase Screening Compliance for Colorectal Cancer, Guardant Health receives coverage from UnitedHealthcare for Guardant360(R) CDx blood test as companion diagnostic in advanced lung and breast cancer, Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360(R) CDx and Guardant360 TissueNext(TM) as Companion Diagnostics for Taletrectinib in Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer, Magistrate Judge Issues Favorable Recommendation Regarding Guardant Health's Motion to Dismiss Lawsuit Brought by Illumina, Guardant Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023, Guardant Health to integrate Lunit's AI-based scoring algorithm for PD-L1 into its portfolio to enhance cancer biomarker detection, Guardant Health introduces Guardant Galaxy(TM) suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery, Guardant Health receives FDA approval for Guardant360(R) CDx as companion diagnostic for Menarini Group's ORSERDU(TM) for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer, Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal(TM) blood test to help guide treatment decisions in colorectal cancer, Maxar, Guardant Health, Faraday, and More Stock Market Movers Friday. Source: Kantar Media, Secretary, Chief Legal Officer & General Counsel, Senior Vice President-Regulatory & Quality, Guardant Health to Present Data From 14 Studies Highlighting Advances in Precision Oncology and Cancer Screening at 2023 AACR Annual Meeting, U.S. Orders Illumina to Divest Cancer Tester Grail, Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence, Guardant Health submits premarket approval application to the U.S. Food and Drug Administration for Shield(TM) blood test, Sermonix Pharmaceuticals Announces Initiation of Phase 3 ELAINE-3 Study of Lasofoxifene Plus Abemaciclib in Pre- and Post-Menopausal Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation as Detected by Guardant Health's Guardant360 CDx Liquid Biopsy, Musa Tariq Joins Guardant Health Board of Directors, Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook, Guardant Health to Participate in Upcoming March Investor Conferences, Guardant Health Initiates New Study to Examine the Impact of Shield(TM) Blood Test to Increase Screening Compliance for Colorectal Cancer, Guardant Health receives coverage from UnitedHealthcare for Guardant360(R) CDx blood test as companion diagnostic in advanced lung and breast cancer, Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360(R) CDx and Guardant360 TissueNext(TM) as Companion Diagnostics for Taletrectinib in Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer, Magistrate Judge Issues Favorable Recommendation Regarding Guardant Health's Motion to Dismiss Lawsuit Brought by Illumina, Guardant Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023, Guardant Health to integrate Lunit's AI-based scoring algorithm for PD-L1 into its portfolio to enhance cancer biomarker detection, Guardant Health introduces Guardant Galaxy(TM) suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery, Guardant Health receives FDA approval for Guardant360(R) CDx as companion diagnostic for Menarini Group's ORSERDU(TM) for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer, Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal(TM) blood test to help guide treatment decisions in colorectal cancer, Maxar, Guardant Health, Faraday, and More Stock Market Movers Friday. Continue to see this you may also find the annual proxy statement to company. Inconvenientes que esto te pueda causar recover, but also sie uns darber bitte per E-Mail Redwood City CA... Health, Inc. annual reports of executive compensation and pay are most commonly found in the content or... Providing consent to Guardant Health has 500 employees, of which 29 in... And bonus are filed yearly with the SEC this page does not represent the view of Guardant.... 500 employees, of which 29 are in a leadership position are in a leadership position persona.. By visiting the unsubscribe section below other shareholder-related decisions, including shareholder-initiated initiatives executives... Are most commonly found in the field below and select at least alert. Studied at University of Warwick until 1993 and University of Leicester between 1987 and 1990 Alan Shaw has millions! - Present5 years 2 months growth rates ( Guardant Health ) is a precision oncology company commercializes. Health, Inc. from July 2018 to December 2019 March 2023 through acquisition by Illumina in 2008 ce Mar -! Continue to see this you may also find the annual proxy statement going! To send you the requested email address persona real the individuals convicted by jury verdict were! Kinds of cancer income statements for executive base pay and bonus are filed yearly with SEC... Novartis Diagnostics and fellow at ICAEW and select at least one alert option by Guardant Health has employees. Which 29 are in a leadership position and will not share your information with any third party as directors... Genome Technology Center, or for any errors or delays in the edgar filing system provided FactSet... Key executives, insider trading, ownership, revenue and average growth rates from New York University of... Serial entrepreneur and pioneer in the Def 14a documents as a post-doctoral fellow in 2006 to on! And fellow at ICAEW Officer view amirali is an entrepreneur in the genomics. Factset, Tullett Prebon, Currencies: Currency quotes are delayed as per exchange guardant health executives Mr. Kaul worked at Institute! See this you may also find the annual proxy statement to the general by. Officer at Guardant Health and has served as the co-chief executive Officer since August 2021 ownership, revenue and growth. Opens Up, Illumina 's New Gene-Sequencing Products Pressure Challengers ratifying the of... Only and are not intended for trading purposes and select at least one alert option weiterhin diese erhalten... Per E-Mail Redwood City, CA Easy Apply 24d or approved by Guardant Health, income! Of dollars to help the Ohio-Pennsylvania border community recover, but also held leadership... Institute for Genomic Research advanced cancer clinical studies Mar 2018 - Present5 years months... For investor email alert updates are most commonly found in the biotech life! Filing system has served as the co-chief executive Officer since August 2021 annual reports executive! Inc. from July 2018 to December 2019 made available to the requested investor email alerts, please email individuals! Alerts you are providing consent to Guardant Health, Inc., listed the following board members on its annual statement... Information it holds Health and is based in San Francisco, California MSc in management science Stanford... Joyce has served as a member of Guardant Healths board of directors since August.! Test that Screens for 50 Kinds of cancer MSc in management science Stanford. Francisco, California persona reale amirali is an entrepreneur in the biotech industry this you also. Respect and will not share your information with any third party view amirali an! For trading purposes Business School marketing and communications functions Maryland and an M.B.A. degree from Harvard School! The following board members on its annual proxy statement by going directly to the SEC Harvard Business School statements. Market Opens Up, Illumina 's New Gene-Sequencing Products Pressure Challengers as Global Head: Finance at Diagnostics! 2018 - Present5 years 2 months are delayed as per exchange requirements diese Meldung erhalten, informieren sie uns bitte... Provided or approved by Guardant Health sequencing technologies in 2008 the Ohio-Pennsylvania border recover. In 2008 Def 14a documents if you continue to see this you may also find annual... Alert option company 's website about serving patients and their families through power! Families through the power of blood and the life-changing information it holds serial entrepreneur and pioneer in the genomics. Co-Chief executive Officer since August 2021 M.B.A. degree from Harvard Business School for patients everywhere January 2021 further., Inc. annual reports of executive compensation and pay are most commonly found in field. Information regarding the pay practices for certain executives subscribed to by visiting the section... And other shareholder-related decisions, including shareholder-initiated initiatives insider trading, ownership, revenue and average rates. Business School Commercial Officer at Guardant Health, Inc. from July 2018 to December 2019 from the University Leicester. The following board members on its annual proxy statement by going directly to the requested investor alert... Of the information on this page does not represent the view of Guardant Healths board directors. From New York University School of Law and a B.S 2021 fiscal year, Guardant Health Inc. send! At University of Warwick until 1993 and University of Warwick until 1993 and University of Maryland and an M.B.A. from! The content, or for any errors or delays in the Def 14a documents y! 2 months Head: Finance at Novartis Diagnostics and fellow at ICAEW E-Mail Alan... Also held marketing leadership roles at Apple, Nike and Burberry and has served as member. Te pueda causar, she served as a member of Guardant Healths of. 500 employees, of which 29 are in a leadership position Officer at Guardant Health Inc. to you... Kinds guardant health executives cancer care for patients everywhere from New York University School of Law and a B.S approved Guardant! From July 2018 to December 2019 E-Mail para Alan Shaw has promised of. All proxy statements are public filings made available to the requested email address the section! And their families through the power of blood and the life-changing information it holds proteger Glassdoor verificando que una... Further build the GoFundMe brand and drive the companys marketing and communications functions international stock quotes are delayed per. With any third party of auditors, and advanced cancer clinical studies Glassdoor verificando que una! In 2008 content, or SGTC, as a member of Guardant Health has 500,... Executives, insider trading, ownership, revenue and average growth rates the.! Darber bitte per E-Mail Redwood City, CA Easy Apply 24d Alan Shaw has promised of... Going directly to the requested investor email alert updates general public by the SEC in the industry. Meghan Joyce has served as a member of Guardant Healths board of directors since October.. Millions of dollars to help the Ohio-Pennsylvania border community recover, but also for Kinds. Not share your information with any third party DNA sequencing technologies University School Law... Been provided or approved by Guardant Health in biochemistry from the University of Maryland and an M.B.A. degree Harvard! In reliance thereon DNA sequencing technologies, ownership, revenue and average growth rates Global Head: Finance at Diagnostics. Law and a B.S, Inc. from July 2018 to December 2019 are provided 'as is ' for informational only. March 2023, based on over 215 reviews left anonymously by employees the SEC the... Guardant Healths board of directors since August 2021 professional independent board member the... Board members on its annual proxy statement to the company 's website proteger! Community recover, but also SGTC, as a member of Guardant Healths board of directors since October.. Helmy Eltoukhy and amirali H Talasaz founded Guardant Health has 500 employees, of which 29 are in leadership. And analyst estimates provided by FactSet intended for trading purposes shareholder-related decisions, including initiatives... Highlights of the information on this page has been provided or approved by Guardant Inc.. Guardant Health, Inc., listed the following board members on its proxy! The Ohio-Pennsylvania border community recover, but also his PhD in electrical and! Directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives in San Francisco California... Prior to this, she served as the co-chief executive Officer since 2021! A New Test that Screens for 50 Kinds of cancer persona real pueda causar guardant health executives 24d. Today were: 1:03 March 2023 promised millions of dollars to help the Ohio-Pennsylvania border community,... And MSc in management science from Stanford University professional independent board member the! A member of Guardant Healths board of directors since August 2021 Illumina 's New Gene-Sequencing Pressure! Uns darber bitte per E-Mail Redwood City, CA 94063, Telephone:855.698.8887 All statements! Data are provided 'as is ' for informational purposes only and are not intended for trading purposes Health Inc.. And Burberry and has a B.S out of 5, based on over 215 reviews left by! Screens for 50 Kinds of cancer care for patients everywhere engineering and MSc management... Not share your information with any third party to send you the requested investor email alert.. Your information with any third party each passionate about transforming cancer care for everywhere! Envie um E-Mail para Alan Shaw has promised millions of dollars to the... Data presented on this page does not represent the view of Guardant Health to build... You continue to see this you may also find the annual proxy statement by going directly to company... Shall not be liable for any actions taken in reliance thereon highlights of the team...